Janus Henderson Horizon Pan European Mid and Large Cap Fund I2 EURRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 7.7 | 15.4 | -2.3 | 9.8 | 5.7 | |
+/-Cat | 3.4 | 0.1 | 6.0 | -1.8 | 2.0 | |
+/-B’mrk | 5.2 | -2.2 | 2.3 | -3.4 | 0.3 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 21/11/2024 | EUR 29.74 | |
Day Change | -0.62% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU0503932674 | |
Fund Size (Mil) 31/10/2024 | EUR 224.63 | |
Share Class Size (Mil) 21/11/2024 | EUR 12.48 | |
Max Initial Charge | - | |
Ongoing Charge 14/02/2024 | 1.00% |
Investment Objective: Janus Henderson Horizon Pan European Mid and Large Cap Fund I2 EUR |
The Fund aims to provide capital growth over the long term. The Fund invests at least 80% of its net assets in equities or equity-related instruments of companies located or listed in Europe (excluding the United Kingdom) or, in the opinion of the Investment Manager, deriving a predominant part of their income from Europe (excluding the United Kingdom). |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Marc Schartz 04/12/2017 | ||
Inception Date 18/02/2011 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Janus Henderson Horizon Pan European Mid and Large Cap Fund I2 EUR | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
TotalEnergies SE | Energy | 4.93 |
ASR Nederland NV | Financial Services | 3.38 |
Novo Nordisk AS Class B | Healthcare | 3.32 |
RELX PLC | Industrials | 2.66 |
AstraZeneca PLC | Healthcare | 2.66 |
Increase Decrease New since last portfolio | ||
Janus Henderson Horizon Pan European Mid and Large Cap Fund I2 EUR |